The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sigal Charles Elliott since 2016.
This trader's CIK number is 1661908.
At the time of last reporting, Sigal Charles Elliott was the Director of Vir Biotechnology, Inc.. (stock ticker symbol VIR).
Also see all insider trading activities at Vir Biotechnology, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | ADAP | 60,000 | $92,100 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | VIR | 5,000 | $119,209 | 0 | $0 | 0 | $0 |
1. Adaptimmune Therapeutics Plc (ADAP)
2. Vir Biotechnology, Inc. (VIR)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-05-19 | ADAP | Buy | 15,000 | 1.56 | 23,400 |
2016-05-18 | ADAP | Buy | 15,000 | 1.55 | 23,250 |
2016-05-17 | ADAP | Buy | 15,000 | 1.53 | 22,950 |
2016-05-16 | ADAP | Buy | 15,000 | 1.50 | 22,500 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-03-01 | VIR | Buy | 2,500 | 22.73 | 56,815 |
2023-01-05 | VIR | Buy | 2,500 | 24.96 | 62,394 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sigal Charles Elliott (Director of Vir Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.